By analyzing serum neuron-derived EVs, the study further explored how exenatide may modify brain insulin signaling pathways
You may also have a substantial elevation in heart rate or blood pressure, but this is less common
The two companies are vying for a share of Indias fast-expanding anti-obesity market, currently valued at Rs 3,0003,500 crore and projected to grow eightfold to Rs 25,000 crore by 2030
What Some Of The Evidence Shows So Far A 2025 brief case series using modelling examined less frequent dosing of GLP-1s for weight maintenance
Below are the next steps in your personalized wellness journey.
Once approved, retatrutide will likely be prescribed to people with obesity who have not responded well to existing GLP 1 medications